Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LEXX | AMGN | VRTX | REGN | BMY |
| Company | Lexaria Bioscience Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.44 | 310.88 | 402.77 | 958.00 | 44.16 |
| High | 3.51 | 312.73 | 407.59 | 962.10 | 44.62 |
| Low | 3.18 | 297.52 | 401.16 | 950.27 | 43.83 |
| Last | 3.37 | 300.04 | 402.50 | 956.13 | 43.83 |
| Change | +0.24 | -11.25 | +1.42 | -0.87 | -0.16 |
| % Change | +7.67% | -3.61% | +0.35% | -0.09% | -0.36% |
| Volume | 263,804 | 3,138,267 | 813,988 | 203,802 | 5,910,044 |
| 20-Day Average Volume | 222,030 | 2,707,891 | 1,023,670 | 511,533 | 14,130,352 |
| Previous Close | 3.13 | 311.29 | 401.08 | 957.00 | 43.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.54 | 273.79 | 398.43 | 910.78 | 47.10 |
| 20-Day Raw Stochastic | 84.15% | 62.98% | 79.98% | 93.85% | 7.09% |
| 20-Day Relative Strength | 56.28% | 62.83% | 49.83% | 59.00% | 29.08% |
| Weighted Alpha | +130.20 | +27.75 | +15.61 | +28.32 | -36.33 |
| Today's Opinion | 80% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 64% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 80% Buy | 8% Sell | 40% Buy | 56% Buy | 16% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +37.80% since 04/29/24 | +8.43% since 04/29/24 | +2.04% since 04/29/24 | +7.20% since 04/29/24 | -1.60% since 04/29/24 |
| Low | 2.44 on 04/30/24 | 272.35 on 04/30/24 | 391.70 on 04/30/24 | 885.01 on 04/30/24 | 43.33 on 05/02/24 |
| High | 3.68 on 05/01/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 44.76 on 04/30/24 |
| 1-Month | |||||
| %Chg | +11.15% since 04/05/24 | +11.01% since 04/05/24 | -0.59% since 04/05/24 | +1.49% since 04/05/24 | -14.41% since 04/05/24 |
| Low | 1.85 on 04/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 3.68 on 05/01/24 | 322.60 on 05/03/24 | 407.59 on 05/06/24 | 962.10 on 05/06/24 | 51.68 on 04/09/24 |
| 3-Month | |||||
| %Chg | +74.74% since 02/06/24 | -5.19% since 02/06/24 | -2.85% since 02/06/24 | +2.02% since 02/06/24 | -10.83% since 02/06/24 |
| Low | 1.85 on 04/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 6.85 on 03/11/24 | 322.60 on 05/03/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +118.71% since 11/06/23 | +9.84% since 11/06/23 | +4.80% since 11/06/23 | +14.94% since 11/06/23 | -16.79% since 11/06/23 |
| Low | 1.20 on 01/04/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 6.85 on 03/11/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,333 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 12,886 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 230,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -6,660,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 150,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -650,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.99 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/09/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 04/12/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |